When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MGTA - Magenta Therapeutics pauses leukemia trial following participant death
Magenta Therapeutics Inc.
Magenta Therapeitics ( NASDAQ: MGTA ) has halted a phase 1/2 trial of MGTA-117 for acute myeloid leukemia and myelodysplastic syndrome following the death of a patients that nay be related to the candidate.
The participant experienced a Grade 5 Serious Adverse Event, respiratory failure and cardiac arrest that resulted in death.
Information regarding the participant had been shares with the US FDA.